Series Listing



Immunotherapy-Induced Rheumatic Diseases: Managing the Intersection of Rheumatology and Oncology

As a result of anticipated exponential growth in the use of ICIs to manage an increasingly long list of cancers, clinicians can expect to encounter increasing numbers of patients with rheumatic irAEs. To meet the educational needs of healthcare providers, this myCME Go video series convenes a leading oncologist and a rheumatologist to discuss the rheumatologic irAEs most commonly observed with ICI agents and how a guideline-driven, stepwise approach to managing these events can best be implemented among members of the collaborative care team.

Each activity offers:
0.50 AMA PRA Category 1 CreditTM
0.50 CNE Contact Hour

A Changing AML Landscape: Adapting Target-Specific Treatments to Individual Patients

For 4 decades, no new agents had been permanently approved for the management of acute myeloid leukemia (AML) in both the newly diagnosed and relapsed/refractory settings. That has changed dramatically in the last 2 years with the approval of 8 new agents and several more in clinical development. This initiative includes activities that provide insight into advances in molecular alterations—FLT3, CD33, IDH-1/2, BCL-2, and others—that may trigger AML in individual patients, and the safety and efficacy of target-specific agents, alone and in combination with other therapies, that inhibit those genetic alterations and have had a significant impact on overall survival.

Each activity offers:
0.75-1.00 AMA PRA Category 1 CreditTM
0.70-1.00 CNE Contact Hour
0.75-1.00 CE for Pharmacists

Getting It Right: Applying Guideline-Directed Medical Therapy

In spite of dramatic improvements in the management of cardiovascular disease in recent decades, morbidity and mortality due to chronic heart failure (HF) remain high. HF is responsible for a shocking five-year mortality of approximately 50%, which is worse than many cancers. Furthermore, gaps between guideline-recommended treatment and clinical practice are causing worse outcomes for patients with HF, who often are sicker than their physicians realize. In this series of programs, a panel of expert faculty address common knowledge and practice gaps in HF management, including emerging best practices for patient-centered care, risk stratification and prognostication, and optimization of medical therapy.

Each activity offers:
0.25-1.25 AMA PRA Category 1 CreditsTM

Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer

This series is intended to improve care of patients with non-small cell lung cancer and head & neck cancer by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Each activity offers:
1.25-2.00 AMA PRA Category 1 CreditsTM
1.25-2.00 CNE Contact Hours

Key Issues in Neuromuscular Blockade and Reversal: Education for the Interprofessional Team

This 3-part series addresses therapeutic options for reversal of neuromuscular blockade (NMB), pharmacoeconomic factors to consider when evaluating options, and a framework for developing a shared model for change that can improve perioperative medication safety and outcomes.

Each activity offers:
0.50-1.50 AMA PRA Category 1 CreditsTM

A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment

The Migraine Toolbox is a free, comprehensive "how to" course in managing migraine. It covers the diagnosis and treatment of this disease. It includes downloadable practical tools - including questionnaires, medication guidelines for clinicians, a patient brochure and other resources. Those with migraine have many symptoms and therefore are seen by a wide range of medical professionals. This educational program will enable primary care physicians, nurses, pharmacists, gastroenterologists, and other non-headache specialists to care for these patients.

Each activity offers:
1.00-2.00 AMA PRA Category 1 CreditsTM
1.00-2.00 CNE Contact Hour
1.00-2.00 CE for Pharmacists
1.00-2.00 CDE Credits

More Than Just a Backache: Addressing the Clinical Challenges of Diagnosing and Treating Axial Spondyloarthritis

This two-part program series has been designed to improve screening of patients with chronic back pain, promote prompt referral to a rheumatologist for diagnostic evaluation, promote the use of validated assessment tools in order to improve early differential diagnosis, increase confidence and competence to select guideline-recommended treatment strategies, and to provide updates on recent therapeutic advances for axial spondyloarthritis (axSpA) and their potential application to patient care.

Each activity offers:
0.75-1.00 AMA PRA Category 1 Credit(s)TM

Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)

This series is intended to improve care of patients with genitourinary cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus.

Each activity offers:
1.25-2.00 AMA PRA Category 1 Credit(s)TM
1.25-2.00 CE for Nurses
1.25-2.00 CE for Pharmacists

Engagement with Novel Therapies and Decision Making Through Breast Cancer Education

Module 1: A focused 30-minute module by Donette Vicente, MD, of Duke Cancer Network on current data on the role of CDK4/6 inhibitors in the treatment of advanced breast cancer and the associated toxicity profiles, and strategies for monitoring and managing adverse events.

Module 2: A focused 30-minute module by Kerri A. Dalton MSN, RN, AOCNS, of Duke Cancer Network on patient communications, shared decision making, monitoring and addressing patient compliance with CDK4/6 inhibitors.

Each activity offers:
0.50 AMA PRA Category 1 CreditsTM
0.50 CNE Contact Hours

Emerging Strategies to Delay Progression in Autosomal-Dominant Polycystic Kidney Disease (ADPKD)

Autosomal-dominant polycystic kidney disease (ADPKD), an inherited disorder that affects 1 to 2 individuals per 1000 worldwide, typically develops insidiously, often causing irreversible renal damage years before the patient develops overt symptoms. Until recently, there have been few tools to protect affected individuals from developing kidney failure at a relatively young age. Now, however, new treatments are available, underscoring the importance of early identification and risk stratification in ADPKD.

These 2 activities—a text-based Case Clinic and an Expert Perspectives video—have been developed to inform nephrologists and primary care physicians alike about best practices and emerging therapies for the care of patients with ADPKD in order to help them address crucial unmet clinical needs.

Each activity offers:
Expert Perspective: 1.25 AMA PRA Category 1 CreditsTM
Case Clinic: 1.00 AMA PRA Category 1 CreditTM

Keeping Up With Sleep

The sheer pace of medical research challenges clinicians who try to keep up with the burgeoning volume of literature related to obstructive sleep apnea (OSA), narcolepsy, excessive daytime sleepiness, and other sleep-related disorders. The Keeping Up With Sleep Journal Club selects key articles and shares expert commentary on them, giving learners an educational tool that helps translate emerging knowledge into improvements in clinical care.

Each activity offers:
0.75 AMA PRA Category 1 CreditTM

Insights and Updates in PAH Treatment: A Series Curriculum

This educational series with faculty, Dan Schuller, MD, is designed for primary care physicians, cardiologists, cardiopulmonologists, and other allied healthcare professionals interested in PAH.

Each activity offers:
0.50 AMA PRA Category 1 CreditTM

7th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia

This series of 3 webcasts is intended to improve care of patients with hematological malignancies such as Hodgkins lymphoma, B-cell lymphoma, multiple myeloma and leukemia by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. Participants will also gain clinical decision-making strategies for integration of novel therapeutic options.

Each activity offers:
1.50-2.00 AMA PRA Category 1 Credit(s)TM
1.50-2.00 CE for Nurses
1.50-2.00 CE for Pharmacists (0.20 CEUs)

Recognition of Sleep Quality, Sleep Disorders and their Diagnosis and Management

Sleep is essential for healthy brain function and physical health, whereas sleep deprivation adversely affects physiological functions including those of the CNS, Immune, Respiratory, Digestive, Cardiovascular, and Endocrine systems. The purpose of this series is to examine the enhancement of slow wave sleep, and the effect this may have on brain health and improved memory consolidation.

Each activity offers:
1.00 AMA PRA Category 1 CreditTM
1.00 AANP Contact Hour

Smoothing the Course of COPD: Practical Strategies for Strengthening Care

Chronic obstructive pulmonary disease (COPD) is a common, eminently treatable, and preventable disease, yet it results in millions of deaths worldwide every year and is a leading cause of disability, alone and in combination with a variety of serious comorbid conditions. This series of videos, which feature a pulmonologist, primary care physician, and pharmacist, will systematically address the current gaps in COPD knowledge and practice and offer practical approaches and resources that can be applied in day-to-day patient care.

Each activity offers:
0.50 AMA PRA Category 1 Credit(s)TM
0.50 CE for Pharmacists

Effective Identification and Resection of Precancerous Lesions in GI Mucosa: Sequential Staining and Screening Techniques

Gastrointestinal (GI) cancer presents a significant cause of morbidity and mortality worldwide. Therefore, there is an urgent need to identify, assess, and remove suspect GI lesions in the GI mucosa at the earliest stages, before they progress and become malignant. The sequenced components of this initiative provide stepwise guidance on the efficient and effective screening, lifting, and resection of precancerous lesions in the GI mucosa.

Each activity offers:
0.25-0.50 AMA PRA Category 1 CreditTM
0.25-0.50 CNE Contact Hour

Assessing Risk and Appropriate Triage of Patients With Worsening Chronic Heart Failure

In this 2-part webcast, 3 experts—an ED physician, a hospitalist, and a cardiologist—discuss optimal approaches to the management of acute decompensated HF.

Each activity offers:
0.50 AMA PRA Category 1 Credit(s)TM

Improving Postoperative Pain Management: Breaking Down Silos in the Multidisciplinary Team

This is a 3-part series on improving postoperative pain management. The courses focus on safety, policies and protocols, and counseling and communication.

Each activity offers:
0.50 AMA PRA Category 1 Credit(s)TM

is free, fast, and customized just for you!




Already a member?

Sign In Now »

is free, fast, and customized just for you!




Already a member?

Sign In Now »